HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-10-22Clinical Trial Update: Kaletra-isentress Treatment Evaluation [Phase 4]
Phase 4 clinical trial evaluating Kaletra (lopinavir/ritonavir) with Isentress (raltegravir) in HIV infection has completed and posted resul…
-
CLINICAL_TRIALS trial_result · 2013-10-21Clinical Trial Update: A Pilot Study Assessing the Integrase Inhibitor GSK1349572 in HIV-infected Persons With Virus Resistant to Raltegravir [Phase 2]
A Phase 2 pilot study evaluated dolutegravir (GSK1349572) in HIV-infected individuals with resistance to raltegravir; the trial has complete…
-
CLINICAL_TRIALS trial_result · 2013-10-18Clinical Trial Update: A Study in Asymptomatic HIV Infected Patients to Investigate Pharmacodynamics, Pharmacokinetics, Safety and Toleration of UK-453,061 [Phase 2]
Pfizer conducted a Phase 2 study in asymptomatic HIV-infected patients to evaluate pharmacodynamics, pharmacokinetics, safety and tolerabili…
-
CLINICAL_TRIALS trial_result · 2013-10-17Clinical Trial Update: Treatment of Acute Hepatitis C Virus in HIV Co-Infection [Phase 4]
Phase 4 trial update on treating acute hepatitis C virus in individuals co-infected with HIV; results completed and posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-10-17Clinical Trial Update: Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women [Phase 2]
Phase 2 trial assessing safety and immune response of the HPV vaccine in HIV-infected women has completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-10-17Clinical Trial Update: "The Once A Day Protease Inhibitor Regimens" [Phase 4]
Phase IV clinical trial update on once-daily protease inhibitor regimens for HIV infection; results were posted in 2013.
-
FDA approval · 2013-10-16FDA Approved: STRIBILD — Supplemental Application (Gilead Sciences, Inc.)
The FDA approved a supplemental application for STRIBILD, a fixed-dose combination antiretroviral, to be produced by Gilead Sciences, Inc.
-
CLINICAL_TRIALS trial_result · 2013-10-11Clinical Trial Update: Interactions Between HIV and Malaria in African Children [Phase 3]
Phase 3 trial evaluating interactions between HIV infection and malaria in African children has completed; the update summarizes the study r…
-
CLINICAL_TRIALS trial_result · 2013-10-10Clinical Trial Update: Safety and Efficacy of Telaprevir in Combination With Peginterferon Alfa-2a and Ribavirin in Subjects Co-Infected With Hepatitis C Virus (HCV) and HIV [Phase 2]
This Phase 2 study evaluated the safety and efficacy of adding telaprevir to peginterferon alfa-2a and ribavirin in people co-infected with …
-
CLINICAL_TRIALS trial_result · 2013-10-08Clinical Trial Update: Safety and Efficacy of the PrePex Device Circumcision When Performed by Nurses [Phase 3]
A Phase 3 study evaluated the safety and efficacy of the PrePex device for adult circumcision performed by nurses. The trial has completed.
-
CLINICAL_TRIALS trial_result · 2013-10-08Clinical Trial Update: Comparing the PrePex™ Device to Surgical MC for Rapid Scale Up of MC in Resource Limited Setting [Phase 2]
A Phase 2 trial in Zimbabwe compared the PrePex non-surgical circumcision device to surgical male circumcision for rapid scale-up in resourc…
-
CLINICAL_TRIALS trial_result · 2013-10-08Clinical Trial Update: Evaluation of Safety and Efficacy of the PrePexTM Device for Rapid Scale up of Adult MC Programs in Zimbabwe [Phase 1]
This completed Phase 1 study evaluated the safety and efficacy of the PrePex device for rapid scale-up of adult medical male circumcision pr…
-
CLINICAL_TRIALS trial_result · 2013-10-07Clinical Trial Update: Zidovudine and Lamivudine Given Once Versus Twice Daily [Phase 1]
Phase 1 study comparing once-daily versus twice-daily dosing of zidovudine and lamivudine in HIV infections; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2013-10-07Clinical Trial Update: Anti-HIV Drug Regimens With or Without Protease Inhibitors and Drug Level Monitoring in HIV Infected Adolescents [Phase 3]
Phase 3 trial in HIV-infected adolescents evaluating regimens with or without protease inhibitors and with drug level monitoring; the study …
-
CLINICAL_TRIALS trial_result · 2013-10-07Clinical Trial Update: The Effects of Anti-HIV Therapy on the Immune Systems of Children and Young Adults Infected With HIV [NA]
This report summarizes a completed clinical trial evaluating the effects of anti-HIV therapy on immune function in children and young adults…
-
CLINICAL_TRIALS trial_result · 2013-10-07Clinical Trial Update: A Study on the Effect of High-Calorie Infant Formula on Growth and Nutrition in HIV-Infected Infants [NA]
Clinical trial update for a study examining the effect of high-calorie infant formula on growth and nutrition in HIV-infected infants; the t…
-
CLINICAL_TRIALS research · 2013-10-07Clinical Trial Update: A Study to Collect Information About HIV-Positive Pregnant Women and Their Babies
A clinical trial studying HIV-positive pregnant women and their babies has completed.
-
FDA approval · 2013-10-02FDA Approved: STRIBILD — Supplemental Application (Gilead Sciences, Inc.)
The FDA approved a supplemental application for STRIBILD, the fixed-dose combination antiretroviral from Gilead Sciences, Inc. The approval …
-
CLINICAL_TRIALS trial_result · 2013-10-01Clinical Trial Update: The Safety and Effectiveness of Adefovir Dipivoxil in the Treatment of HIV-Infected Patients [Phase 3]
This update reports on a Phase 3 trial evaluating the safety and effectiveness of adefovir dipivoxil in HIV-infected patients, including tho…
-
CLINICAL_TRIALS trial_result · 2013-10-01Clinical Trial Update: A Comparison of Two Anti-HIV Treatment Plans
A completed clinical trial comparing two antiretroviral treatment plans for HIV infection.
-
CLINICAL_TRIALS trial_result · 2013-10-01Clinical Trial Update: A Pilot Study of the Short-Term Effects of Antiretroviral Management Based on Plasma Genotypic Antiretroviral Resistance Testing (GART) Compared With Antiretroviral Management Without Plasma GART
This is a completed pilot clinical trial comparing antiretroviral management guided by plasma genotypic resistance testing (GART) versus man…
-
CLINICAL_TRIALS trial_result · 2013-10-01Clinical Trial Update: A Comparison of Two Caloric Supplements in the Prevention of Weight Loss in Patients With AIDS Who Take Daily Multivitamin and Mineral Supplements
This completed clinical trial compares two caloric supplements to prevent weight loss in people with HIV infection/AIDS who are taking daily…
-
CLINICAL_TRIALS trial_result · 2013-10-01Clinical Trial Update: A Study of Psychosocial and Behavioral Determinants of Differential Rates of Participant Compliance in CPCRA Protocols
This update reports results from an NIAID study examining psychosocial and behavioral factors that influence participant compliance across C…
-
CLINICAL_TRIALS trial_result · 2013-10-01Clinical Trial Update: A Study of Two Adherence Plans to Help HIV-Positive Patients Take Their Medications Correctly [NA]
A completed clinical trial evaluated two adherence plans to help HIV-positive patients take their medications correctly.
-
CLINICAL_TRIALS research · 2013-10-01Clinical Trial Update: Two-Stage Tuberculin (PPD) Skin Testing in Individuals With Human Immunodeficiency Virus (HIV) Infection [NA]
This clinical trial update covers two-stage tuberculin skin testing (PPD) in individuals with HIV infection. The study status is completed.